The invention provides methods for treating primary disorders of mood and affect, including depressive disorders, anxiety, and sleep disorders and CNS disorders comprising the administration of a neurotoxin.
Botulinum Toxin for Primary Disorders of Mood and Affect using Neurotransmitter CNS imaging Studies